Stay up to date with the latest clinical business news in the industry!
- Bellicum offloads cell therapy plant in switch to outsourced productionBellicum sells cell therapy manufacturing plant to MD Anderson Cancer Center, strikes master service agreement. ... read more4 weeks ago
- BioIVT in deal with upcyte on liver cells for in-vitro researchBioIVT taps into the advantages of hepatic cells for toxicology evaluations and screening studies, securing exclusive distribution agreement with upcyte. ... read more4 weeks ago
- PharSafer adopts Oracle’s cloud solution for pharmacovigilanceThe CRO will utilize the platform to provide clinical and post-marketing drug safety services to clients. ... read more4 weeks ago
- CRO Novotech invests in Algernon, lands deal to run trialNovotech set to invest in Algernon Pharmaceuticals after landing contract to run Phase II clinical trial. ... read more4 weeks ago
- New CDMO plans $1.1bn cell and gene therapy plantA newly founded CDMO has outlined plans to invest $1.1bn to become the worldâs biggest cell and gene therapy service provider. ... read more4 weeks ago
- White males overrepresented in clinical trials for first-time cancer treatmentThe levels of patients enrolling for a clinical trial as a first form of treatment for cancer is 0.1%, whilst also being predominantly made up of white males with private insurance. ... read more4 weeks ago
- EMA welcomes Court of Justice transparency findingEMA wins courtâs decision in favor of citizens being able to access clinical study and toxicology reports submitted to the agency. ... read more1 month ago
- WCG continues acquisitive streak with biostatistical consultancy buyoutWCG adds to its portfolio of solutions for clinical trial sponsors by acquiring Statistics Collaborative. ... read more1 month ago
- Boom in number of UK cell and gene therapy clinical trialsYear-on-year, the number of trials for advanced therapeutics has doubled, meaning that the UK now represents 12% of all global clinical trials in the area. ... read more1 month ago
- Reporting of clinical trial results is ‘poor and not improving’A study on the disclosure of the results of clinical trials found that a majority did not meet the publication deadline, with non-industry most likely to fail to publish. ... read more1 month ago
- Bellicum offloads cell therapy plant in switch to outsourced productionBellicum sells cell therapy manufacturing plant to MD Anderson Cancer Center, strikes master service agreement. ... read more4 weeks ago
- BioIVT in deal with upcyte on liver cells for in-vitro researchBioIVT taps into the advantages of hepatic cells for toxicology evaluations and screening studies, securing exclusive distribution agreement with upcyte. ... read more4 weeks ago
- PharSafer adopts Oracle’s cloud solution for pharmacovigilanceThe CRO will utilize the platform to provide clinical and post-marketing drug safety services to clients. ... read more4 weeks ago
- CRO Novotech invests in Algernon, lands deal to run trialNovotech set to invest in Algernon Pharmaceuticals after landing contract to run Phase II clinical trial. ... read more4 weeks ago
- New CDMO plans $1.1bn cell and gene therapy plantA newly founded CDMO has outlined plans to invest $1.1bn to become the worldâs biggest cell and gene therapy service provider. ... read more4 weeks ago
- White males overrepresented in clinical trials for first-time cancer treatmentThe levels of patients enrolling for a clinical trial as a first form of treatment for cancer is 0.1%, whilst also being predominantly made up of white males with private insurance. ... read more4 weeks ago
- EMA welcomes Court of Justice transparency findingEMA wins courtâs decision in favor of citizens being able to access clinical study and toxicology reports submitted to the agency. ... read more1 month ago
- WCG continues acquisitive streak with biostatistical consultancy buyoutWCG adds to its portfolio of solutions for clinical trial sponsors by acquiring Statistics Collaborative. ... read more1 month ago
- Boom in number of UK cell and gene therapy clinical trialsYear-on-year, the number of trials for advanced therapeutics has doubled, meaning that the UK now represents 12% of all global clinical trials in the area. ... read more1 month ago
- Reporting of clinical trial results is ‘poor and not improving’A study on the disclosure of the results of clinical trials found that a majority did not meet the publication deadline, with non-industry most likely to fail to publish. ... read more1 month ago